Expression and prognostic impact of lncRNAs in acute myeloid leukemia-Reference-Cited by-同舟云学术

Expression and prognostic impact of lncRNAs in acute myeloid leukemia

Published:2014-12-15 Issue:52 Volume:111 Page:18679-18684
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proc Natl Acad Sci USA

Author:

Garzon Ramiro,Volinia Stefano,Papaioannou Dimitrios,Nicolet Deedra,Kohlschmidt Jessica,Yan Pearlly S.,Mrózek Krzysztof,Bucci Donna,Carroll Andrew J.,Baer Maria R.,Wetzler Meir,Carter Thomas H.,Powell Bayard L.,Kolitz Jonathan E.,Moore Joseph O.,Eisfeld Ann-Kathrin,Blachly James S.,Blum William,Caligiuri Michael A.,Stone Richard M.,Marcucci Guido,Croce Carlo M.,Byrd John C.,Bloomfield Clara D.

Funder

HHS | NIH | National Cancer Institute (NCI)

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference49 articles.

1. Ries LAG, et al. (eds) (2008) SEER Cancer Statistics Review, 1975–2005. National Cancer Institute, Bethesda, MD. Available at seer.cancer.gov/csr/1975_2005/, based on November 2007 SEER data submission, posted to the SEER website, 2008. Accessed October 17, 2014

2. Acute myeloid leukemia in the elderly: Assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study;Leith;Blood,1997

3. Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461

4. Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from AMLSG trial AML HD98-B

5. Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome:

Cited by 206 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of long noncoding RNAs in the diagnosis, prognosis and therapeutic biomarkers of acute myeloid leukemia;Annals of Hematology;2024-09-12

2. A 69 long noncoding RNA signature predicts relapse and acts as independent prognostic factor in pediatric AML;Blood Advances;2024-06-14

3. MIAT LncRNA: A multifunctional key player in non-oncological pathological conditions;Non-coding RNA Research;2024-06

4. Effect of lncRNA XIST on acute myeloid leukemia cells via miR-142-5p-PFKP axis;Hematology;2024-02-02

5. Long non-coding RNAs emerge as a novel prognostic indicator in pediatric acute myeloid leukemia;Translational Pediatrics;2023-10